MedPath

Electrophysiological Biomarkers in MTLE Patients.

Not Applicable
Terminated
Conditions
Mesial Temporal Lobe Epilepsy
Interventions
Device: Asynchronous distributed multi-electrode stimulation (ADMES) using an implantable neurostimulation device
Registration Number
NCT04710004
Lead Sponsor
Emory University
Brief Summary

The investigators plan to enroll individuals with medical temporal lobe epilepsy who are undergoing surgical workup with clinically implanted intracranial electrodes. The study intends to administer computerized memory tasks and stimulation during the intracranial Electroencephalography (EEG) monitoring period.

Detailed Description

This is a nonrandomized interventional trial that will apply brain stimulation via clinically implanted intracranial electrodes to subjects with medial temporal lobe epilepsy with the purpose of identifying biomarkers related to the pre-ictal state; to perform an acute parameter search to determine the stimulation pattern that most effectively modifies these biomarkers and to identify changes in memory (free recall) during asynchronous distributed multi-electrode stimulation (ADMES).

Recruitment & Eligibility

Status
TERMINATED
Sex
All
Target Recruitment
1
Inclusion Criteria
  1. Provision of signed and dated informed consent form
  2. Male or female, aged 18-65
  3. Diagnosed with lesional or non-lesional mesial temporal (hippocampal) seizure onset confirmed on SEEG monitoring
  4. Implanted with depth electrodes for localization of seizure onset with multiple hippocampal electrode arrays

Exclusion criteria:

  1. Any patient who is unwilling or unable to provide consent
  2. Women who are pregnant
  3. Patients under 18 years
  4. Incarcerated persons
Exclusion Criteria

Not provided

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Arm && Interventions
GroupInterventionDescription
Brain stimulation via clinically implanted electrodesAsynchronous distributed multi-electrode stimulation (ADMES) using an implantable neurostimulation deviceBrain will be stimulated in different patterns including synchronized or asynchronous current.
Primary Outcome Measures
NameTimeMethod
Change in Intracranial EEG Recording: Synchrony From BaselineBaseline, up to 6 weeks postintervention

Synchrony will be compared between baseline/sham and stimulation trials to determine if asynchronous stimulation modulates synchrony during the preictal, ictal or post ictal states. Synchrony is a measure of how any pair of regions communicate with one another. Synchrony is measured as the correlation \[-1 to 1\] between two time series.

The investigators anticipate that a decrease in synchrony (correlation approaching 0) is associated with improved outcome.

Change in Intracranial EEG Recording: Spectral Power From BaselineBaseline, up to 6 weeks postintervention

Spectral power will be compared between baseline/sham and stimulation trials to determine if asynchronous stimulation modulates spectral power during the preictal, ictal or post ictal states. Spectral power is measured in microvolts. A change in either direction from baseline is associated with a better outcome.

Secondary Outcome Measures
NameTimeMethod
Changes in Memory During Brain Stimulation From BaselineBaseline, up to 6 weeks postintervention

Patients will be asked to recall a list of words after a 20-second delay in which they will do simple math problems to ensure long-term memory encoding. Three \~1-2-hour sessions will be performed; each session will consist of 24 free recall tasks (12 during ADMES and 12 with no stimulation). The memory score will be assessed as the percentage correct out of 12. The higher the percentage recalled, the better the score.

Trial Locations

Locations (1)

Epilepsy monitoring unit (EMU) at Emory University Hospital

🇺🇸

Atlanta, Georgia, United States

© Copyright 2025. All Rights Reserved by MedPath